Trials / Conditions / Awake Fiberoptic Intubation

Awake Fiberoptic Intubation

7 registered clinical trials studyying Awake Fiberoptic Intubation — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients NCT06601036	Tanta University	N/A
Recruiting	Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation NCT05736198	University of Illinois at Chicago	—
Completed	Nerve Block Vs Sedation Infusion for Awake Fiberoptic Intubation. NCT06651905	Cairo University	N/A
Completed	Dexmedetomidine Versus Ketamine-midazolam Sedation in Awake Fiberoptic Intubation in Suspected Difficult Airwa NCT06946212	Zagazig University	Phase 4
Completed	Atomization Vs. Nebulization for Airway Topicalization During Awake Nasotracheal Fiberoptic Intubation NCT05320731	Zagazig University	N/A
Completed	Comparison of Two Different Types of "Spray as You go" Technique for Awake Fiberoptic Intubation NCT01995292	Johannes Gutenberg University Mainz	N/A
Completed	A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic In NCT00383890	Hospira, now a wholly owned subsidiary of Pfizer	Phase 3